ERY-TAB DR 333 MG TABLET

Erythromycin
$3.3321per EA

Strength

333 mg/1

NDC

24338012403

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA062298

On Market Since

4/18/2011

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price History

1W

0.0%

1M

-0.7%

3M

-9.6%

6M

-7.4%

1Y

-11.2%

3Y

-60.9%

5Y

-60.9%

All

-60.9%